Search

everythinglearnresearchcommunity

for

Search:↓

Drospirenone can hide symptoms of certain hormonal disorders, complicating diagnosis.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

The ACTH/MC2R system is crucial for controlling hair growth cycles in mice.

Lower MC2R expression may contribute to alopecia areata.

Alopecia areata may involve stress-related changes affecting hormone receptors, leading to reduced cortisol production.

A woman's cyclic Cushing syndrome was caused by a tumor in her adrenal gland that produced ACTH.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Vitamin B12 deficiency can cause skin darkening and increased blood vessels, but treatment can improve symptoms.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Low androgen levels can still cause female pattern hair loss.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

A man's health improved after treating his undiagnosed adrenal insufficiency, which caused fatigue and weight loss.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.